comparemela.com

Latest Breaking News On - Ram selvaraju - Page 4 : comparemela.com

H.C. Wainwright Keeps Their Buy Rating on Verona Pharma (VRNA)

H.C. Wainwright analyst Ram Selvaraju reiterated a Buy rating on Verona Pharma (VRNA – Research Report) today and set a price target of $3.

United-kingdom
London
City-of
Ram-selvaraju
Verona-pharma
Michael-ja-walker
Moonlake-immunotherapeutics
Verona-pharma-plc
Research-report
Strong-buy
Pharma-plc

H.C. Wainwright Reaffirms Their Buy Rating on Verona Pharma (VRNA)

In a report released today, Ram Selvaraju from H.C. Wainwright reiterated a Buy rating on Verona Pharma (VRNA – Research Report), with a p.

London
City-of
United-kingdom
Verona-pharma
Ram-selvaraju
Moonlake-immunotherapeutics
Michael-ja-walker
Inovio-pharmaceuticals
Verona-pharma-plc
Research-report
Strong-buy
Pharma-plc

H.C. Wainwright Remains a Buy on Reviva Pharmaceuticals Holdings (RVPH)

H.C. Wainwright analyst Ram Selvaraju reiterated a Buy rating on Reviva Pharmaceuticals Holdings (RVPH – Research Report) today and set a .

New-york
United-states
Ram-selvaraju
Moonlake-immunotherapeutics
Inovio-pharmaceuticals
Reviva-pharmaceuticals-holdings
Maxim-group
Tenzing-acquisition-corp
Research-report
Pharmaceuticals-holdings
Strong-buy

Verona Pharma (VRNA) Gets a Buy from H.C. Wainwright

H.C. Wainwright analyst Ram Selvaraju reiterated a Buy rating on Verona Pharma (VRNA – Research Report) today and set a price target of $3.

London
City-of
United-kingdom
Michael-ja-walker
Moonlake-immunotherapeutics
Verona-pharma
Ram-selvaraju
Inovio-pharmaceuticals
Verona-pharma-plc
Research-report
Strong-buy
Pharma-plc

UroGen Pharma Ltd. (NASDAQ:URGN) Q1 2023 Earnings Call Transcript

Operator: Good morning, ladies and gentlemen. Thank you for standing by, and welcome to the UroGen Pharma Q1 2023 Earnings Call. Please be advised that today s conference is being recorded.

Chicago
Illinois
United-states
San-diego
California
Americans
Joseph-jacob
Sandip-prasad
Matt-kaplan
Ram-selvaraju
Vincent-perrone
Dong-kim

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.